This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Universität Autonoma De Barcelona. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Albert Ribera Sánchez: Innovator in Gene Therapy
Introduction
Albert Ribera Sánchez is a notable inventor based in Santa Eulàlia de Ronçana, Spain. He has made significant contributions to the field of gene therapy, particularly through his work on the Fibroblast growth factor 21 (FGF21) gene therapy. His innovative approach has the potential to impact various medical applications.
Latest Patents
Albert Ribera Sánchez holds 1 patent for his groundbreaking work in gene therapy. His patent focuses on the Fibroblast growth factor 21 (FGF21) gene therapy, which aims to address various health issues related to metabolic disorders.
Career Highlights
He is currently affiliated with the Universitat Autònoma de Barcelona, where he continues to advance his research and development in gene therapy. His work has garnered attention in the scientific community for its potential applications in treating metabolic diseases.
Collaborations
Albert has collaborated with esteemed colleagues, including Maria Fàtima Bosch Tubert and Ivet Elias Puigdomènech. These collaborations have enriched his research and contributed to the advancement of gene therapy.
Conclusion
Albert Ribera Sánchez is a pioneering inventor whose work in gene therapy is paving the way for future innovations in medical science. His contributions are significant and hold promise for improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile